DrugCard utilizes AI-driven data intelligence to automate literature screening for pharmacovigilance teams, achieving up to 70% time savings compared to manual processes. This platform enhances drug safety monitoring by providing accurate, real-time insights from over 1,000 local medical journals in more than 100 languages.
Funding
$290K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NNFounders
Product
Problem
Pharmacovigilance teams face increasing pressure to monitor drug safety across a growing volume of local medical literature, often in multiple languages. Manual screening processes are time-consuming, costly, and prone to human error, potentially leading to delayed detection of adverse drug reactions and compliance issues. The need for continuous, accurate, and scalable monitoring is further complicated by rising personnel costs and increasing regulatory scrutiny.
Solution
DrugCard offers an AI-powered data intelligence platform that automates the screening of local medical journals for pharmacovigilance purposes. The platform leverages proprietary OCR technology and natural language processing (NLP) to extract relevant drug safety information from over 1,500 journals in more than 100 languages. By automating literature review, DrugCard enables pharmacovigilance teams to identify potential adverse events faster, improve data accuracy, and reduce screening time by up to 70%. The platform provides continuous monitoring, traceable results, and scalable coverage to meet the evolving demands of global drug safety surveillance.
Target Audience
DrugCard is designed for Marketing Authorization Holders (MAHs), Contract Research Organizations (CROs), and freelance pharmacovigilance specialists involved in drug safety monitoring and regulatory compliance.
Features
- AI-driven literature screening for automated adverse event detection
- Coverage of 1,500+ local medical journals across 66+ countries
- Support for 100+ languages with proprietary OCR technology for high accuracy
- Real-time alerts for new drug mentions and weekly summary reports
- Customizable keyword search in multiple languages
- Integration with existing pharmacovigilance workflows
- Regulatory intelligence module for monitoring compliance requirements